Cite
HARVARD Citation
Schiff, M. et al. (n.d.). FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra). Annals of the rheumatic diseases. pp. A469-A470. [Online].